Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Warning Letter Blasts Mylan’s Lax API Impurity Controls
Cites Equipment Cleaning And Monitoring Of Recovered Solvents For Impurities
Sep 03 2020
•
By
Joanne S. Eglovitch
FDA Tells Mylan To Learn From Earlier Mistakes • Source: Shutterstock
More from Manufacturing
More from Business